Al Mabarrah and Burjeel Holdings sign MoU to broaden access to treatment in Abu Dhabi
A new partnership between Burjeel Holdings and Al Mabarrah International Charitable Association sets out a structured, privacy-focused framework to help eligible patients receive care at Burjeel Medical City.
Partnership to connect charity funding with clinical care
Burjeel Holdings and Al Mabarrah International Charitable Association signed a Memorandum of Understanding on 16th September 2026 to help cover all or part of the cost of treatment for cases that meet approved eligibility criteria through charitable campaigns and initiatives.
The agreement was signed by Omran Al Khoori, Member of the Board of Directors, Burjeel Holdings, and Rashid bin Jarash, Director-General of the Global Al‑Mabarrah Charitable Society, in the presence of Dr Ali Rashid Al Nuaimi, Chairman of the Board of Directors of Al Mabarrah International Charitable Association, and Dr Shamsheer Vayalil, Chairman and CEO of Burjeel Holdings.
How the scheme will work
Under the MoU, Burjeel Medical City (BMC), the flagship facility of Burjeel Holdings, will identify patients who require financial assistance and provide medical reports and cost estimates to support each case. Al Mabarrah will review submissions in line with its established criteria and procedures, deciding whether to launch a fundraising campaign or to allocate support through its own charitable programmes.
Once a case is approved and funding secured, the designated amount will be used for treatment at BMC. The hospital will provide the necessary care, monitor patient progress and share the relevant clinical reports and documentation with Al Mabarrah to confirm that treatment is ongoing or has been completed.
Governance, transparency and dignity
The partners emphasised clear governance and transparent processes to ensure contributions are used responsibly and reach the intended beneficiaries. The arrangement is intended to give donors greater clarity about how donations are spent while connecting community support to verified clinical need.
Patient privacy and dignity are central to the agreement. Medical and personal information will be protected, and names, photographs or medical reports will not be used in campaigns or awareness materials unless all necessary consents have been obtained and use falls within the permitted scope. Approved funds will be applied solely for the specified treatment, with each stage of implementation and follow‑up documented.
Dr Ali Rashid Al Nuaimi said the collaboration aims to establish a scalable and sustainable model to support eligible patients and to encourage broader community and healthcare‑sector participation in measurable humanitarian work consistent with the UAE’s values of solidarity and social responsibility. Dr Shamsheer Vayalil noted that partnerships between healthcare providers and charities can play an important role in addressing gaps in access to treatment.
Source: WAM